Comparison of CD34 + cell mobilization, blood graft cellular composition, and post‐transplant outcome in myeloma patients mobilized with filgrastim or pegfilgrastim added to low‐dose cyclophosphamide: A prospective multicenter study-Reference-Cited by-同舟云学术

Comparison of CD34 + cell mobilization, blood graft cellular composition, and post‐transplant outcome in myeloma patients mobilized with filgrastim or pegfilgrastim added to low‐dose cyclophosphamide: A prospective multicenter study

Published:2021-09-09 Issue:11 Volume:61 Page:3202-3212
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Anu Partanen¹^ORCID,Antti Turunen¹²^ORCID,Raija Silvennoinen¹³,Marja Pyörälä¹,Jaakko Valtola¹,Timo Siitonen⁴,Mervi Putkonen⁵,Marja Sankelo⁶,Anu Sikiö⁷,Karri Penttilä⁸⁹,Taru Kuittinen¹,Jukka Pelkonen¹⁰¹¹,Pentti Mäntymaa¹⁰,Esa Jantunen¹²¹²,Ville Varmavuo¹³

Affiliation:

1. Department of Medicine Kuopio University Hospital Kuopio Finland

2. Institute of Clinical Medicine University of Eastern Finland Kuopio Finland

3. Department of Hematology Helsinki University Hospital Comprehensive Cancer Center and University of Helsinki Helsinki Finland

4. Department of Medicine Oulu University Hospital Oulu Finland

5. Department of Medicine Turku University Hospital Turku Finland

6. Department of Internal Medicine Tampere University Hospital Tampere Finland

7. Department of Medicine Central Hospital of Central Finland Jyväskylä Finland

8. The Finnish Medicines Agency Fimea Kuopio Finland

9. Department of Medicine Savonlinna Central Hospital Savonlinna Finland

10. Laboratory Center of Eastern Finland Kuopio Finland

11. Department of Clinical Microbiology University of Eastern Finland Kuopio Finland